Lymphocyte G-protein coupled receptor kinase 2 (GRK2) protein, a biomarker of sympathetic dysfunction, is highly expressed in patients with AD, correlating with the severity of cognitive impairment [12]. Here, GRK2 is linked to Cognitive impairment.